Evidence map›Paper›PMID 31118275›Full record

ArticleThe Journal of biological chemistry2019

Conserved Glu-47 and Lys-50 residues are critical for UDP-

M Agustina Toscanini, M Belén Favarolo, F Luis Gonzalez Flecha, Berit Ebert, Carsten Rautengarten, Luis M Bredeston

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Biosynthesis of GlcNAc-richThe Journal of biological chemistry · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

M Agustina ToscaniniFrom the Departamento de Química Biológica-IQUIFIB, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires-CONICET, Ciudad Autónoma de Buenos Aires, Junín 956 (1113), Argentina and.
M Belén FavaroloFrom the Departamento de Química Biológica-IQUIFIB, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires-CONICET, Ciudad Autónoma de Buenos Aires, Junín 956 (1113), Argentina and.ORCID 0000-0002-4349-4085
F Luis Gonzalez FlechaFrom the Departamento de Química Biológica-IQUIFIB, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires-CONICET, Ciudad Autónoma de Buenos Aires, Junín 956 (1113), Argentina and.ORCID 0000-0003-2828-7907
Berit Ebertthe School of BioSciences, University of Melbourne, Melbourne, Victoria 3010, Australia.
Carsten Rautengartenthe School of BioSciences, University of Melbourne, Melbourne, Victoria 3010, Australia.ORCID 0000-0001-5850-746X
Luis M BredestonFrom the Departamento de Química Biológica-IQUIFIB, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires-CONICET, Ciudad Autónoma de Buenos Aires, Junín 956 (1113), Argentina and bredes@qb.ffyb.uba.ar.ORCID 0000-0002-1272-8344
Consejo Nacional de Investigaciones Científicas y Técnicas · ARThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleotide sugar transporters (NSTs) regulate the flux of activated sugars from the cytosol into the lumen of the Golgi apparatus where glycosyltransferases use them for the modification of proteins, lipids, and proteoglycans. It has been well-established that NSTs are antiporters that exchange nucleotide sugars with the respective nucleoside monophosphate. Nevertheless, information about the molecular basis of ligand recognition and transport is scarce. Here, using topology predictors, cysteine-scanning mutagenesis, expression of GFP-tagged protein variants, and phenotypic complementation of the yeast strain Kl3, we identified residues involved in the activity of a mouse UDP-GlcNAc transporter, murine solute carrier family 35 member A3 (mSlc35a3). We specifically focused on the putative transmembrane helix 2 (TMH2) and observed that cells expressing E47C or K50C mSlc35a3 variants had lower levels of GlcNAc-containing glycoconjugates than WT cells, indicating impaired UDP-GlcNAc transport activity of these two variants. A conservative substitution analysis revealed that single or double substitutions of Glu-47 and Lys-50 do not restore GlcNAc glycoconjugates. Analysis of mSlc35a3 and its genetic variants reconstituted into proteoliposomes disclosed the following: (i) all variants act as UDP-GlcNAc/UMP antiporters; (ii) conservative substitutions (E47D, E47Q, K50R, or K50H) impair UDP-GlcNAc uptake; and (iii) substitutions of Glu-47 and Lys-50 dramatically alter kinetic parameters, consistent with a critical role of these two residues in mSlc35a3 function. A bioinformatics analysis revealed that an E

Indexed as

Amino Acid SequenceAnimalsGlutamic AcidGolgi ApparatusIon TransportLysineMiceModels, MolecularProtein ConformationSequence HomologySodium-Phosphate Cotransporter Proteins, Type IIcUridine Diphosphate N-AcetylglucosamineUridine MonophosphateGlutamic AcidLysineSlc34a3 protein, mouseSodium-Phosphate Cotransporter Proteins, Type IIcUridine Diphosphate N-AcetylglucosamineUridine Monophosphateantiportercongenital glycosylation disorderglycoprotein biosynthesisGolgimembrane proteinmembrane transportsecretory pathwaysolute carrier family 35 member A3 (SLC35A3)structural modelUDP-GlcNAc metabolism

Identifiers

PMID31118275
PMCPMC6664187
OpenAlexW2945080354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.